GREENVILLE, SC–(BUSINESS WIRE)–docs24, a leading provider of digital and print asset management solutions for the clinical research industry, today announced that it has entered into a strategic partnership with Intrinseque Health.
Intrinseque Health provides clinical supplies and equipment to investigational sites around the world. To do this, they implement strong clinical supply and equipment plans. These plans include procurement/procurement, storage, kitting, relabeling, distribution and retrieval strategies. Their customers include pharmaceutical, biotechnology, medical device and contract research organization (CRO) organizations and are served by a management team that has over 145 years of combined experience supporting global trials across a wide range of therapeutic areas.
The new agreement creates a partnership that allows both organizations to expand the services offered to their customers while continuing to provide exemplary levels of customer service. docs24 has the capability to provide content and document management while Intrinseque Health provides the supplies and equipment necessary to conduct regulatory compliant trials on time and within budget.
“Throughout our partner selection process, docs24 was clearly the best choice and stood out from the crowd in all areas,” said Nitin Jain, CEO of Intrinseque Health. “Their proven ability to deliver high quality work under tight deadlines pairs well with Intrinseque Health’s commitment to providing the same to its clients. Together, we are well positioned to expand our position in today’s highly competitive market by removing the administrative burdens typically associated with the management, delivery and retrieval of content, documents, supplies and clinical trial equipment.
Jim Rae, CEO of docs24, said, “We are delighted to have been selected as a strategic partner for Intrinseque Health. Their commitment to meeting the needs of their customers aligns incredibly well with our culture. They use their years of expertise in this area to ensure that trials are not delayed due to poor supply management. I look forward to seeing how this partnership will allow us to better serve our growing global customer base.
docs24 provides a bespoke digital and print asset management platform that offers the ability to take over client administration tasks, manage the end-to-end process with just a few keystrokes, and ultimately , to restore many lost hours to their customers. Each user can produce artwork specific to their needs, within a controlled platform ensuring that everything follows company guidelines. With their bespoke software platforms and technology framework, they create customized solutions for our clients to control their document flow. Whether it’s creating on-brand marketing materials every time, controlling the use of brand assets (such as templates, images, and other information), streamlining content creation, or to manage printing to reduce costs and time, the docs24 platform is developed to adapt to the unique requirements of their customers, providing them with precisely what they need, when they need it. For more information, please visit their website at https://www.docs24.co.uk/.
About Intrinsic Health
Intrinseque Health is an EN ISO 13485:2016 certified global clinical trial supply and logistics provider, helping pharmaceutical, biotechnology, medical device and contract research (CRO) organizations manage essential clinical supplies and equipment on clinical sites around the world. Their drug development experts understand the importance of maintaining study timelines. The importance of supplies reaching sites and ultimately patients, and working tirelessly to ensure your trial supplies reach their intended destination safely, compliantly and securely. Global headquarters are in Singapore with offices in the US, China, Taiwan and the Netherlands with future growth targeting India, UK and South Korea. For more information, please visit their website at https://intrinsequehealth.com/.